Thus, thanks to the high sensitivity of Well-TEMP-seq, we can provide insights into the 5-AZA-CdR induced anti-tumor response of STAT1, HEYL, and PITX1 TFs activation in the early stage of treatment (e.g., in the first three days), which has not been unveiled before. The gene discussed is PITX1; the disease is neoplasm.